Opportunity

SAM #140D0426Q0826

Procurement of Element Biosciences AVITI24 Sequencing and Spatial Biology System for NCI CCR

Buyer

Interior Business Center Acquisition Services Directorate

Posted

August 11, 2026

Respond By

August 27, 2026

Identifier

140D0426Q0826

NAICS

334516

This procurement seeks to acquire advanced genomics and spatial biology technology for the National Cancer Institute's Center for Cancer Research (CCR). - Government Buyer: - U.S. Department of the Interior, Interior Business Center, Acquisition Services Directorate - National Cancer Institute (NCI), Center for Cancer Research (CCR), CCR Genomics Core - OEM Highlight: - Element Biosciences is the sole Original Equipment Manufacturer (OEM) specified - Products Requested: - Element Biosciences AVITI24 Sequencing and Spatial Biology System (1 unit) - Integrated next-generation sequencing, high-resolution imaging, spatial cytoprofiling, and direct in situ sequencing - Includes hardware, optics, imaging components, computing hardware, software licenses, accessories, and all necessary components for full operation - Includes delivery, installation, testing, validation, manufacturer warranty, technical support, and user training - Individually Addressable Lanes Enablement (1 unit) - Enables flexible sample processing on the sequencing system - Services Requested: - Training on equipment, software, consumables, and associated sequencing and spatial cytoprofiling workflows for NCI personnel - Provided by Element Biosciences application specialists or qualified personnel within one week of installation - Notable Requirements: - System will be jointly operated by the CCR Genomics Core and the High-Throughput Imaging Facility (HiTIF) - Delivery and installation required within 4 to 12 weeks after contract award - Training must be provided within one week of installation - Payment upon government acceptance of delivery and installation - The procurement is intended to expand sequencing capacity and support advanced spatial biology applications at NCI

Description

The purpose of this acquisition is to enhance the shared research capabilities of the National Cancer Institute (NCI), Center for Cancer Research (CCR), by acquiring an Element Biosciences AVITI24 Sequencing System for joint operation by the CCR Genomics Core and the CCR High-Throughput Imaging Facility (HiTIF).

View original listing